TGA moves to regulate autologous stem cells

A growing concern about the use of unproven autologous stem cell therapies to treat a wide range of conditions such as osteoarthritis has led the TGA to consider tightening its regulations. In a consultation paper published on Tuesday the TGA says concerns centre around the safety of the products, lack of evidence to support their ...

Already a member?

Login to keep reading.

© 2022 the limbic